定量化学交换饱和转移MRI诊断甲状腺相关眼病活动性的前瞻性可行性研究
这项前瞻性研究纳入88例活动性TAO、76例非活动性TAO和30例健康对照,计算眼外肌CEST MRI的MTR及1、2、3.5 ppm的MTRasym。活动性TAO患者MTR较低而MTRasym较高,MTR与MTRasym(1 ppm)独立关联TAO活动性,两者联合鉴别活动性与非活动性TAO的AUC达0.805。
要点
- 活动性TAO眼外肌MTR低于非活动性TAO,MTRasym(1、2、3.5 ppm)高于非活动性TAO(均P<0.001)。
- MTR与CAS呈负相关(r=-0.402),MTRasym(1、2、3.5 ppm)与CAS呈正相关(r=0.369、0.350、0.349,均P<0.001)。
- MTR联合MTRasym(1 ppm)鉴别活动性与非活动性TAO的AUC为0.805,优于任一单独参数。
核心结论
- MTR与MTRasym(1 ppm)独立关联TAO活动性,两者联合可提升鉴别活动性与非活动性TAO的诊断效能,提示其可能作为指导TAO治疗的定量影像生物标志物。
研究设计与样本
- 前瞻性可行性研究,纳入88例活动性TAO、76例非活动性TAO和30例健康对照,计算眼外肌(每眼取一块代表性肌肉,每人2次测量)CEST MRI的MTR及1、2、3.5 ppm的MTRasym,并与临床活动度评分(CAS)行Spearman相关及logistic回归分析。
关键影像表现/征象
- 活动性TAO患者眼外肌MTR值低于非活动性TAO患者(P<0.001)。
- 活动性TAO患者MTRasym(1 ppm)、MTRasym(2 ppm)、MTRasym(3.5 ppm)均高于非活动性TAO患者(均P<0.001)。
诊断标准与关键数值
- MTR与CAS呈负相关(r=-0.402;P<0.001)。
- MTRasym(1 ppm)、MTRasym(2 ppm)、MTRasym(3.5 ppm)与CAS呈正相关(r分别为0.369、0.350、0.349;均P<0.001)。
- MTR和MTRasym(1 ppm)与TAO活动性独立相关。
- MTR鉴别活动性与非活动性TAO的AUC为0.772。
- MTRasym(1 ppm)鉴别活动性与非活动性TAO的AUC为0.730。
临床应用与阅片要点
- 对TAO患者行CEST MRI时,可定量测量眼外肌MTR及1、2、3.5 ppm的MTRasym以辅助评估疾病活动性。
- MTR与MTRasym(1 ppm)联合应用较任一单独参数诊断效能更高,阅片时可结合两者判断活动性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This prospective study evaluated the feasibility of chemical exchange saturation transfer (CEST) MRI for assessing disease activity in thyroid-associated ophthalmopathy (TAO).
MATERIALS AND METHODS: A total of 88 patients with active TAO, 76 with inactive TAO, and 30 healthy controls were enrolled. CEST MRI-derived magnetization transfer ratio (MTR) and MTR asymmetry (MTRasym) at 1 ppm, 2 ppm, and 3.5 ppm were calculated. Clinical data, MTR, and MTRasym values for the extraocular muscles (one representative muscle per eye, yielding two measurements per participant) were compared among the groups. Spearman's correlation was used to examine associations between imaging parameters and the clinical activity score (CAS) in patients with TAO. Logistic regression analysis was used to identify independent associations between imaging parameters and disease activity in patients with TAO (active vs. inactive). Receiver operating characteristic (ROC) analysis was conducted to evaluate the diagnostic performance for discriminating active from inactive TAO.
RESULTS: Patients with active TAO showed lower MTR values (P < 0.001) and higher MTRasym (1 ppm), MTRasym (2 ppm), and MTRasym (3.5 ppm) (all P < 0.001) compared with those with inactive TAO. MTR was negatively correlated with CAS (r = -0.402; P < 0.001), while MTRasym (1 ppm), MTRasym (2 ppm), and MTRasym (3.5 ppm) were positively correlated with CAS (r = 0.369, 0.350, and 0.349, respectively; all P < 0.001). MTR and MTRasym (1 ppm) were independently associated with TAO activity. The areas under the ROC curve (AUCs) for MTR and MTRasym (1 ppm) in discriminating active from inactive TAO were 0.772 and 0.730, respectively. Combining MTR with MTRasym (1 ppm) significantly improved diagnostic performance compared with either parameter alone, achieving an AUC of 0.805 (P = 0.029 and 0.001).
CONCLUSION: MTR and MTRasym (1 ppm) were independently associated with TAO activity. Their combination further enhanced diagnostic performance in distinguishing active from inactive TAO, suggesting their potential as quantitative imaging biomarkers to guide treatment in patients with TAO.
引用
- Wang Y, Zhou W, Cui Y, et al. Quantitative Chemical Exchange Saturation Transfer MRI for Diagnosing Thyroid-Associated Ophthalmopathy Activity: A Prospective Feasibility Study. Korean J Radiol. 2026. PMID: 41592551. doi:10.3348/kjr.2025.1101
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。